2seventy bio, Inc.

NasdaqGS:TSVT Stok Raporu

Piyasa değeri: US$254.9m

2seventy bio Yönetim

Yönetim kriter kontrolleri 0/4

2seventy bio CEO'su Chip Baird, Apr2024 tarihinde atandı, in görev süresi bir yıldan az. in toplam yıllık tazminatı $ 2.93M olup, şirket hissesi ve opsiyonları dahil olmak üzere 17.7% maaş ve 82.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.12% ine doğrudan sahiptir ve bu hisseler $ 294.10K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 0.6 yıl ve 1.2 yıldır.

Anahtar bilgiler

Chip Baird

İcra Kurulu Başkanı

US$2.9m

Toplam tazminat

CEO maaş yüzdesi17.7%
CEO görev süresiless than a year
CEO sahipliği0.1%
Yönetim ortalama görev süresiless than a year
Yönetim Kurulu ortalama görev süresi1.2yrs

Son yönetim güncellemeleri

Recent updates

There's No Escaping 2seventy bio, Inc.'s (NASDAQ:TSVT) Muted Revenues

Oct 03
There's No Escaping 2seventy bio, Inc.'s (NASDAQ:TSVT) Muted Revenues

2seventy bio, Inc.'s (NASDAQ:TSVT) Share Price Is Matching Sentiment Around Its Revenues

Jul 04
2seventy bio, Inc.'s (NASDAQ:TSVT) Share Price Is Matching Sentiment Around Its Revenues

Downgrade: Here's How Analysts See 2seventy bio, Inc. (NASDAQ:TSVT) Performing In The Near Term

May 11
Downgrade: Here's How Analysts See 2seventy bio, Inc. (NASDAQ:TSVT) Performing In The Near Term

2seventy Bio: Maximizing ABECMA's Potential To Fuel A Turnaround

Apr 03

These Analysts Just Made A Massive Downgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) EPS Forecasts

Mar 07
These Analysts Just Made A Massive Downgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) EPS Forecasts

2seventy bio, Inc. (NASDAQ:TSVT) Held Back By Insufficient Growth Even After Shares Climb 49%

Feb 06
2seventy bio, Inc. (NASDAQ:TSVT) Held Back By Insufficient Growth Even After Shares Climb 49%

Here's Why We're Watching 2seventy bio's (NASDAQ:TSVT) Cash Burn Situation

Jan 17
Here's Why We're Watching 2seventy bio's (NASDAQ:TSVT) Cash Burn Situation

2seventy bio, Inc. (NASDAQ:TSVT) Shares Fly 44% But Investors Aren't Buying For Growth

Dec 13
2seventy bio, Inc. (NASDAQ:TSVT) Shares Fly 44% But Investors Aren't Buying For Growth

Industry Analysts Just Made A Dazzling Upgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts

May 05
Industry Analysts Just Made A Dazzling Upgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts

Industry Analysts Just Upgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts By 12%

Mar 21
Industry Analysts Just Upgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts By 12%

2seventy bio, Inc. (NASDAQ:TSVT) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

Mar 19
2seventy bio, Inc. (NASDAQ:TSVT) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate

Oct 04
We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate

2seventy Bio: This Spinoff In The CAR-T Space Is Attractive

Sep 08

2seventy bio Prospects

Aug 23

Time To Worry? Analysts Just Downgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Outlook

Aug 12
Time To Worry? Analysts Just Downgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Outlook

2seventy bio GAAP EPS of -$2.02 misses by $0.09, revenue of $13.48M misses by $3.04M

Aug 10

CEO Tazminat Analizi

Chip Baird'un ücretlendirmesi 2seventy bio'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$156m

Mar 31 2024n/an/a

-US$223m

Dec 31 2023US$3mUS$518k

-US$218m

Sep 30 2023n/an/a

-US$184m

Jun 30 2023n/an/a

-US$180m

Mar 31 2023n/an/a

-US$215m

Dec 31 2022n/an/a

-US$254m

Sep 30 2022n/an/a

-US$292m

Jun 30 2022n/an/a

-US$284m

Mar 31 2022n/an/a

-US$291m

Dec 31 2021US$2mUS$491k

-US$292m

Sep 30 2021n/an/a

-US$308m

Jun 30 2021n/an/a

-US$320m

Mar 31 2021n/an/a

-US$222m

Dec 31 2020US$2mUS$475k

-US$120m

Tazminat ve Piyasa: Chip 'nin toplam tazminatı ($USD 2.93M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.47M ).

Tazminat ve Kazançlar: Chip şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Chip Baird (52 yo)

less than a year

Görev süresi

US$2,927,118

Tazminat

Mr. William D. Baird III, also known as Chip, serves as Chief Executive Officer, President and Director of 2seventy bio, Inc. since April 1, 2024. He was Principal Financial Officer and Principal Accountin...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
William Baird
CEO, President & Directorless than a yearUS$2.93m0.12%
$ 294.1k
Victoria Eatwell
Chief Financial Officerless than a yearVeri yok0.66%
$ 1.7m
Jessica Snow
Senior VP of Quality and Head of Operationsless than a yearVeri yok0.30%
$ 771.0k
Anna Truppel-Hartmann
Chief Medical Officerless than a yearVeri yokVeri yok

0.6yrs

Ortalama Görev Süresi

45yo

Ortalama Yaş

Deneyimli Yönetim: TSVT 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 0.6 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
William Baird
CEO, President & Directorless than a yearUS$2.93m0.12%
$ 294.1k
Eli Casdin
Independent Directorless than a yearVeri yokVeri yok
Nick Leschly
Chairman of the Boardless than a yearUS$9.08m1.43%
$ 3.6m
Charles Newton
Independent Directorless than a yearVeri yokVeri yok
Marcela Maus
Independent Director3.1yrsUS$290.00k0.028%
$ 72.3k
Denice Torres
Lead Independent Director3.1yrsUS$304.00k0.038%
$ 96.6k
Sarah J. Glickman
Independent Director3.1yrsUS$303.00k0.028%
$ 72.3k
Wei Lin
Independent Director1.7yrsUS$622.05k0.019%
$ 48.2k

1.2yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: TSVT 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 1.2 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.